Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 2,621 | 2,670 | 2,627 | 4,642 | 4,071 |
| Operating Income | -2,621 | -2,670 | -2,627 | -4,642 | -4,071 |
| Other Income | 0 | 0 | 0 | 0 | 67 |
| Pre-tax Income | -2,621 | -2,670 | -2,627 | -4,642 | -4,004 |
| Net Income Continuous | -2,621 | -2,670 | -2,627 | -4,642 | -4,004 |
| Net Income | $-2,621 | $-2,670 | $-2,627 | $-4,642 | $-4,004 |
| EPS Basic Total Ops | -5.20 | -5.20 | -5.00 | -9.20 | -11.40 |
| EPS Basic Continuous Ops | -5.11 | -5.22 | -4.91 | -9.18 | -11.49 |
| EPS Diluted Total Ops | -5.20 | -5.20 | -5.00 | -9.20 | -11.40 |
| EPS Diluted Continuous Ops | -5.11 | -5.22 | -4.91 | -9.18 | -11.49 |
| EBITDA(a) | $-2,621 | $-2,670 | $-2,627 | $-4,642 | $-4,071 |